{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:18:59Z","timestamp":1760501939461},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T00:00:00Z","timestamp":1335398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00213-012-2723-z","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T09:35:02Z","timestamp":1335346502000},"page":"357-360","source":"Crossref","is-referenced-by-count":13,"title":["Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder"],"prefix":"10.1007","volume":"223","author":[{"given":"Iain","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dene","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Catani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,26]]},"reference":[{"issue":"6","key":"2723_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.brainresbull.2003.06.001","volume":"61","author":"P Brambilla","year":"2003","unstructured":"Brambilla P, Hardan A et al (2003) Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull 61(6):557\u2013569","journal-title":"Brain Res Bull"},{"issue":"1","key":"2723_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris KD, Molski TF et al (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302(1):381\u2013389","journal-title":"J Pharmacol Exp Ther"},{"key":"2723_CR3","doi-asserted-by":"crossref","unstructured":"Courchesne E, Campbell K et al (2010) Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 1380:138\u2013145","DOI":"10.1016\/j.brainres.2010.09.101"},{"issue":"1","key":"2723_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-011-2194-7","volume":"216","author":"CA Erickson","year":"2011","unstructured":"Erickson CA, Stigler KA et al (2011) A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology 216(1):85\u201390","journal-title":"Psychopharmacology"},{"issue":"6","key":"2723_CR5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"E Fombonne","year":"2009","unstructured":"Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65(6):591\u2013598","journal-title":"Pediatr Res"},{"issue":"8","key":"2723_CR6","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ajp.2008.07101574","volume":"165","author":"G Grunder","year":"2008","unstructured":"Grunder G, Fellows C et al (2008) Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry 165(8):988\u2013995","journal-title":"Am J Psychiatry"},{"key":"2723_CR7","volume-title":"ECDEU Assessment Manual for Psychopharmacology-Revised","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU Assessment Manual for Psychopharmacology-Revised. Department of Health Services, Rockville, MD, U.S. Department of Health and Human Services, pp 218\u2013222"},{"issue":"1","key":"2723_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1362361301005001002","volume":"5","author":"K Jarbrink","year":"2001","unstructured":"Jarbrink K, Knapp M (2001) The economic impact of autism in Britain. Autism 5(1):7\u201322","journal-title":"Autism"},{"issue":"3","key":"2723_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopsych.2006.09.040","volume":"62","author":"M Langen","year":"2007","unstructured":"Langen M, Durston S et al (2007) Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry 62(3):262\u2013266","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2723_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M et al (1994) Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659\u2013685","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"2723_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003495-200969050-00003","volume":"69","author":"RP Malone","year":"2009","unstructured":"Malone RP, Waheed A (2009) The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 69(5):535\u2013548","journal-title":"Drugs"},{"issue":"11","key":"2723_CR12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, Owen R et al (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48(11):1110\u20131119","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2723_CR13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00023210-200923060-00005","volume":"23","author":"G Masi","year":"2009","unstructured":"Masi G, Cosenza A et al (2009) Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. CNS Drugs 23(6):511\u2013521","journal-title":"CNS Drugs"},{"issue":"7","key":"2723_CR14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/11591700-000000000-00000","volume":"25","author":"JL Matson","year":"2011","unstructured":"Matson JL, Sipes M et al (2011) Issues in the management of challenging behaviours of adults with autism spectrum disorder. CNS Drugs 25(7):597\u2013606","journal-title":"CNS Drugs"},{"issue":"Pt 2","key":"2723_CR15","first-page":"268","volume":"128","author":"GM McAlonan","year":"2005","unstructured":"McAlonan GM, Cheung V et al (2005) Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 128(Pt 2):268\u2013276","journal-title":"Brain"},{"issue":"Suppl 4","key":"2723_CR16","first-page":"15","volume":"69","author":"CJ McDougle","year":"2008","unstructured":"McDougle CJ, Stigler KA et al (2008) Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 69(Suppl 4):15\u201320","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2723_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L et al (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533\u20131540","journal-title":"Pediatrics"},{"issue":"10","key":"2723_CR18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biopsych.2009.07.007","volume":"66","author":"CM Schumann","year":"2009","unstructured":"Schumann CM, Barnes CC et al (2009) Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol Psychiatry 66(10):942\u2013949","journal-title":"Biol Psychiatry"},{"issue":"11","key":"2723_CR19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1345\/aph.1D147","volume":"37","author":"JA Staller","year":"2003","unstructured":"Staller JA (2003) Aripiprazole in an adult with Asperger disorder. Ann Pharmacother 37(11):1628\u20131631","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2723_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2004.14.455","volume":"14","author":"KA Stigler","year":"2004","unstructured":"Stigler KA, Posey DJ et al (2004) Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14(3):455\u2013463","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"2723_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/cap.2008.093","volume":"19","author":"KA Stigler","year":"2009","unstructured":"Stigler KA, Diener JT et al (2009) Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. J Child Adolesc Psychopharmacol 19(3):265\u2013274","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2723-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2723-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:12:36Z","timestamp":1558642356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2723-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,26]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2723-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,26]]}}}